AbbVie Inc. (ABBV)

Healthcare

$261.28

LAST CLOSE · OCT 1

AbbVie Inc. (ABBV) is a Healthcare stock tracked by StreetAlpha. It last closed at $261.28 on Oct 1. ABBV reports earnings on Fri, Oct 30, 2026. The average 12-month price target from 16 analysts is $284.00 (+8.7% from the last close), with a high of $315.00 and a low of $247.00. Analyst consensus is Strong Buy, based on the latest ratings from 16 firms (13 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ABBV, 0% of them bullish and 100% bearish. In the past 30 days there were 22 dark pool prints totaling $34.3M, the largest $12.7M.

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions.

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABBV is in one of them and how their past ABBV trades turned out.

StreetAlpha hasn't covered ABBV in an article yet. Here's the latest on the wider market.